SomaLogic, Inc. (SLGC) Tops Q2 EPS by 3c, beats revenue

SomaLogic, Inc. (NASDAQ: SLGC) reported Q2 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $20.5 million versus the consensus estimate of $19.82 million.

For earnings history and earnings-related data on SomaLogic, Inc. (SLGC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c